HCW Biologics Inc. revenue for the last year amounted to 2.84 M USD, the most of which — 2.84 M USD — came from its highest performing source at the moment, Novel Immunotherapies, the year earlier bringing 6.72 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought HCW Biologics Inc. 2.84 M USD, and the year before that — 6.72 M USD.